# US 2012/0253022 A1 · Method of removing protein-bound deleterious substances during extracorporeal renal replacement treatment

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0253022 A1
- Document ID: US20120253022A1
- Status: Published application
- Kind: A1
- Application number: 13/494,506
- Filed: 2012-06-12
- Published: 2012-10-04
- Earliest claimed: 2008-10-16
- Assignees: Fresenius Medical Care Holdings, Inc.
- Inventors: Peter Kotanko; Nathan W. Levin
- Web page: https://patentgrep.com/patent/US20120253022A1

## CPC

- A61M 1/16: with membranes
- A61M 1/3431: {upstream of the filter}
- A61M 1/3458: {having electrolytes not present in the dialysate}
- A61M 1/3687: {Chemical treatment (A61M1/3675 takes precedence)}
- A61M 1/3679: {by absorption (A61M1/3675 takes precedence)}
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

The invention is directed to a method of removing a deleterious substance bound to a protein in blood of a patient by introducing a displacer substance into the blood under conditions in which the displacer substance replaces deleterious substance bound to the protein, thereby resulting in additional unbound deleterious substance in the blood, and removing unbound deleterious substance from the blood by extracorporeal renal replacement treatment.

## Claims

### Claim 1

A method of removing a deleterious substance bound to a protein in a biological liquid comprising:
a) introducing a displacer substance into the biological liquid under conditions in which the displacer substance replaces deleterious substance bound to the protein, thereby resulting in additional unbound deleterious substance in the biological liquid; and
b) removing unbound deleterious substance from the biological liquid.

### Claim 2 (depends on 1)

The method of claim 1, wherein the deleterious substance comprises a drug.

### Claim 3 (depends on 2)

The method of claim 2, wherein the drug comprises warfarin, salicylate, indomethacine, and furosemide.

### Claim 4 (depends on 3)

The method of claim 3, wherein the protein comprises α1-acid glycoprotein.

### Claim 5 (depends on 4)

The method of claim 4, wherein the displacer substance has a higher binding affinity to the protein than the deleterious substance.

### Claim 6 (depends on 1)

The method of claim 1, wherein displacer substance is returned to the patient and provides the patient with a benefit.

### Claim 7 (depends on 8)

The method of claim 8, wherein the displacer substance comprises bilirubin.

### Claim 8 (depends on 4)

The method of claim 4, wherein the biological liquid is selected from the group consisting of peritoneal fluid, interstitial fluid, and transcellular fluid, and any combinations thereof.
